AVADEL PHARMACEUTICALS (AVDL)
IE00BDGMC594 - Common Stock
| TTM (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -156.84M | -160.28M | -137.46M | -77.33M | 7.03M | |||
| Depreciation Amortization | 1.72M | 1.77M | 1.49M | 820.00K | 1.69M | |||
| Income Taxes - Deferred | N/A | 0.00 | 26.03M | -15.67M | -7.43M | |||
| Change In Working Capital | -7.14M | -3.00M | 24.54M | 3.70M | -14.32M | |||
| Interest Paid | 2.93M | 5.25M | 9.66M | 6.47M | 6.47M | |||
| Taxes Paid | N/A | 0.00 | -29.06M | 80.00K | -1.70M | |||
| Other non cash items | 34.28M | 33.00M | 15.11M | 11.18M | -35.70M | |||
| OPERATING CASH FLOW | -127.98M | -128.51M | -70.30M | -77.31M | -48.73M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | 0.00 | -720.00K | -30.00K | -100.00K | |||
| Other Investing Activity | -33.78M | -50.09M | 80.41M | 56.96M | -69.62M | |||
| INVESTING CASH FLOW | -33.78M | -50.09M | 79.70M | 56.93M | -69.72M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -21.16M | -38.66M | -8.65M | N/A | 0.00 | |||
| Stock Issued/Repurchased | 109.61M | 148.36M | 28.00M | 260.00K | 179.68M | |||
| Other Financing Activity | N/A | 25.64M | -4.80M | N/A | 0.00 | |||
| FINANCING CASH FLOW | 114.08M | 135.34M | 14.54M | 260.00K | 179.68M | |||
| Exchange Rate Effect | 69.00K | 455.00K | -660.00K | -900.00K | 720.00K | |||
| CHANGE IN CASH | -47.61M | -42.81M | 23.28M | -21.02M | 61.95M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -127.98M | -128.51M | -70.30M | -77.31M | -48.73M | |||
| Capital Expenditure | N/A | 0.00 | -720.00K | -30.00K | -100.00K | |||
| FREE CASH FLOW | -127.98M | -128.51M | -71.02M | -77.34M | -48.83M | |||
All data in USD